Eli Lilly and Co
Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more
Check out the companies making the biggest moves midday: AppFolio — The cloud-based business software provider climbed 7% after an upgrade to overweight from equal weight at KeyBanc, with a 12-month price target of $285, according to FactSet’s StreetAccount service. AST SpaceMobile — Shares in the space-based broadband cellular network dropped 6% after more than […]
Read More
Stocks making the biggest moves premarket: Jefferies, Oracle, Fifth Third, Micron and more
Check out the companies making headlines in premarket trading. Regional bank stocks — The subsector ticked higher after driving down the broader market on Thursday. Zions rose more than 1% on the back of a Baird upgrade , while Western Alliance bounced by less than 1%. The SPDR S & P Regional Banking ETF (KRE) […]
Read More
Stock futures are slightly lower after regional bank worries fuel market sell-off: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 16, 2025. Jeenah Moon | Reuters U.S. stock futures were slightly lower on Thursday night after the previous session saw a sell-off fueled by concerns about regional banks’ loan practices. Futures tied to the Dow Jones Industrial […]
Read More
Stocks making the biggest moves after hours: Novo Nordisk, Interactive Brokers, CSX and more
Check out the companies making headlines in after-hours trading. CSX Corporation — Shares of the railroad jumped 2% on the back of its strong quarterly results. CSX reported adjusted earnings of 44 cents per share on revenue of $3.59 billion for its third quarter, just beating analysts’ earnings expectations of 42 cents per share on […]
Read More
Novo Nordisk to buy Akero for up to $5.2 billion for promising liver drug
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Novo Nordisk said on Thursday it would buy Akero Therapeutics for up to $5.2 billion to add its promising experimental liver disease drug, in the first major deal […]
Read More
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]
Read More
Santoli’s Wednesday market wrap-up: Mixed but resilient tape pushes stocks to new highs
(These are the market notes on today’s action by Mike Santoli, CNBC’s Senior Markets Commentator. See today’s video update from Mike above.) A new quarter but the same old routine in the markets: A mixed but resilient tape pushing the benchmark index to new highs through persistent momentum in core AI plays, retail-trader favorites and […]
Read More
Stocks making the biggest moves midday: Pfizer, Nike, Conagra, Corteva, GEO Group, Tesla, Reddit and more
Check out the companies making the biggest moves midday: Drug stocks — Shares of drugmakers rallied a second day as investors bet the industry will strike more deals with the Trump administration. On Tuesday, Pfizer received a three-year exemption to tariffs in exchange for investing in domestic manufacturing and discounting drug prices for Medicaid patients. Pfizer […]
Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]
Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise. The company last week said it would buy […]
Read More